#pharmaceutical solutions limited

[redsaurrce]

LOVE SHOT - DOSE 4 <no, not Shin-won too>

synopsis 💉 Where jk becomes the part of an experiment where he wasn't supposed to take the love shot but ends up taking it in high dose and gets obsessed with yn by mistake

pairing 💉 YANDERE Scientist!jeon jungkook ft. Jimin x Scientist!fem reader

genre 💉 scientist!au , smut (minors DNI)

word count 💉 2,644

warnings 💉 kissing, profanity, jungkook is needy AF(as always), cock warming, unhealthy obsession, hella possesive, boobsucking, jungkook realizes something, what the hell jimin?

DOSE 3

taglist 💉 @aajjks @effielumiere @dearsullix @canarystwin @yourslut16 @imwithurmother @perfectlyfangirling @pnibts @bloodline1632 @hopeonysus @roundedreluv12 @jub-jub @maqsxi @kooscameras @jungkooksleftbigtoe13 @thatblena @yawnyanii @viridiphile @milkxgukk @outro-kook @puppiliciouslove @mata0-0mata @pk-jimin @jungchanie @ziraspells @twisted-loved @lunaofsun @inlovewithallmusic @sassyfoxunknown @teugiie @hsaranghoe @jjhmk @mryuyux @xxoverthinkerxx @fandems @hollyverday @ohmygodddsblog @fly-on-the-wall @lookformyvoice @slutforwwh @shakashakaa @meikoo @emochicksasukeee @dearly-somber

@mymomsaid-no @madnesstaking0ver @miyoung23 @outofst1le @jiminstreble @kanvis @k3lynn @imagine-this-motherfucker @dontcallmeelle @jkbabiey @1-in-abillion @bangmechanpls @uarmyhore @devils-blackrose @hrndez2008 @azur3s @erennjim @cherryunie @vynmin @fragmentof-indifference

You paced around your room waiting for Shin-won's call. With passing days, you saw less and less hope in the antidote when you noticed hardly any changes in Jungkook, rather he has grown a lot more fiesty, asking you to warm up his cock because "it hurts Y/N, can you please help me out?" Or let him suck on your boobs "to calm his racing mind and let him sleep soundly".

You were in a complex situation and you had no one to turn to except Shin-won who was working as a team. You had a long talk with Shin-won over call while Jungkook was asleep in the early morning.

You knew that if someone else got to know about Jungkook's situation, there will be unnecessary ruckus among your collegues, not to mention about the people who are waiting for you to mess up and seize the chance to drag you down, there were just too many hungry eyes looking out for your experiment to fail.

When you told Shin-won about Jungkook's health without going into the explicit details, he said that he had a good friend in States who is also a pharmaceutical scientist.

He said he'll try to reach her and then call you back. And right now you were waiting for that call.

The ring of your phone distracted you from your worries, "Hey! Did you contact her?"

"Uh-huh! I told ya she'll help us no matter what! Also she told me that she needs to check Jungkook herself."

"Herself? You mean she'll come here?" You asked him.

"Yep! She said she'll take the earliest flight and will be here tonight. I'll come over to your house with her." He answered.

"Okay that's great then, escort her safely from the airport."

"Sure!"

--

You had briefed to Jungkook about Shin-won and his friend coming over tonight to discuss about the solution for the love shot. Although Jungkook felt a little bit dissapointed that soon his reason to stay with you will be over, he still had to act happy for it.

When you opened the door, you greeted Shin-won and his said friend with a huge smile. "Hi, I'm Shin-won's friend Sucrose, you must be Y/N, nice to meet you." She forwarded her hand for a handshake and you returned the friendly gesture, "Yes I am and this here, is Jungkook, Sucrose come inside."

"I've heard everything from Shin-won and I will help you guys. From what I have gathered is that the suggested antidote didn't work on Jungkook? Am I right?" Sucrose asked as she took a seat on your couch.

"Yes you are." You answered.

"It was triple the safe limit?" She asked again to make sure.

"Yes, that's correct." You said.

"Alright I get it now, we need one more person to test the triple limit on." She suggested.

"WHAT??? Sucrose, we can't risk another person." Shin-won was bewildered.

She looked at him, "I'm not saying this for fun, it's been only few minutes since I'm here yet I can strongly feel how much Jungkook is trying to maintain his composure." She licked her lips and further added, "We need one more person so that I can confirm whether Jungkook is immune to the antidote or not, in that case we need to make a new antidote for him. There are many more possibilities and the only way to confirm it.. is to create another subject. You know the rule right? The more number, the less will be the error."

Jungkook sighed, "Y/N keeps chanting that all the time."

"Well, you're right Sucrose, I won't lie by saying that I have not thought about that but I just can't think of risking one more person." You said. "But if that's the only hope for us then, we need someone descreet. I can't imagine what will be the public reaction once they know about this, just the thought of it makes me shiver." You said anxiously.

"Then.. it has to be someone among ourselves, Shin-won, what do you say?" Sucrose raised her eyebrows.

"Huh? What??" He was caught off guard, "You want to test it on me? Me??" He asked with wide eyes.

"Yeah why? And the person you will see will be Y/N." She said in a straightforward tone.

"Wait! wait! wait!" Jungkook stood up all of a sudden, "Y/N is already busy with me, how can she handle one more? I'm against it! If that's our only way out, why don't you be the person he sees first, Miss Sucrose?"

"I very well might be that person Mr. Jungkook but I can't be by his side for I have to be busy with the experiments. As a scientist, we need to take risks and sacrifices many times, especially the scientists of your and my kind." She sighed, "What do you think Y/N, I assume Mr. Jungkook will listen to you and your junior Shin-won will listen to you as well."

You let out a deep sigh, all sorts of possibilities started flooding your mind. What if Shin-won ends the same as Jungkook? Ugh! You don't even want to picture all the things you do with Jungkook to do with him. It feels so wrong yet you are practically left with no other choice.

"Okay, I'll do it." You said with a frown.

"Are you serious Y/N??? What are you thinking???" Jungkook's insides were boiling at your response, no way in hell was he sharing you with anyone.

"Y/N, why are you agreeing to this?" Shin-won asked you in disbelief.

"Calm down you both. I have a reason to agree to this and at times like this, we must act professionally so I expect nothing from you except to sail through this till the end. Sucrose, will you start with your experiment?" You asked.

She nodded and turned towards Shin-won, "Shin-won, did you bring the shots?"

"Shots?- Ah you told me to bring it over with me because you had this plan from the start?" He asked her.

"Of course, now give them to me and Y/N.. I heard you have a laboratory in your house, do you have the necessary equipments?" She asked you.

Goodness! Shin-won really loves to boast how your house has a lab room, doesn't he?

"Yes, I do." You said while side-eyeing Shin-won while he awkwardly chuckled.

"Okay then please lead the way." She said.

--

You attached the wire chords to Shin-won's scalp and plugged in the monitor while Sucrose put on a mask and prepered the doses, she followed the exact same steps as Shin-won had with Jungkook.

When she injected the third dose, she silently gestured for you to come and stand in front of him. "Open your eyes Shin-won." You said and he slowly opened his eyes.

He blinked for a few seconds and took a good look at your face while Jungkook stood near the monitor noting down the records of the graph pattern.

Shoot! There it was! The loud shrill noise from the monitor and just like Jungkook, Shin-won's body temperature started to rise which soon followed with him blacking out.

--

The next morning Shin-won had regained his consciousness while you and Jungkook looked out for him. "Hey! Are you feeling okay?" You asked.

Jungkook helped him sit up and handed him a glass of water, "Yes I am.. so.. how long was I lying here for?"

"7 hours!" Jungkook immediately answered with his arms folded.

Shin-won frowned, "Just 7? What happened to the 18 hour duration? It's even lesser than half of Jungkook's duration."

"I know right, seems like you had a good night's sleep." Sucrose said as she came with a syringe. "Now that you are awake, I need your blood for the sample." She said as she rolled up his sleeve and took out blood from him.

"So, how are you feeling? Attracted to.. Y/N?" Even though Jungkook hated every single word that came out of his mouth, he still couldn't resist the curiousity.

Shin-won gulped as he looked at you, he hissed a bit. "Why? Is anything wrong?" You asked him.

"Y/N, why are you standing so close to Jungkook?" He said with a slight frown.

Jungkook's eyes went wide and he closed his fist involuntarily from anger.

You blinked, "what?"

Shin-won then closed his eyes and touched his forehead, "Y/N, I feel hot, can you please come and touch me?"

Jungkook's fist was throbbing from how tight it was fisted, he was ready to throw punches right then and there.

Meanwhile you sensed something was wrong, you narrowed your eyes, "Nice acting Shin-won. Stop faking it already." You said with arms folding up.

He tsked, "Doggone it!"

"What? You were faking it?" Jungkook frowned in confusion.

"Ugh yes, c'mon y/n i was about to have some fun." Shin-won pouted.

"You think this is funny?" Jungkook stepped ahead with the question.

"Ok fine i was gonna give up anyway by looking at that mad fist." He pointed towards Jungkook's hand.

Jungkook rolled his eyes, "Good decision."

You nodded to yourself while thinking about the antidote's reaction period, "Hmm.. it takes minimum of 4 hours and maximum 12 hours for the antidote to remove loveshot's symptoms, i assume in your case it has already worked?"

Jungkook who was listening to you turned towards Shin-won, "You really dont feel anything for y/n?"

He chuckled, "I don't."

Jungkook felt so relieved at his words, lord he was really pissed.

Sucrose fixed her glasses and said, "Now now i need Jungkook and Shin-won to come with me to our lab's korean branch, Y/N.. would you like to assist as well?"

"Ah.. you mean the lab you were working in States has a branch in korea as well?" You asked her with raised eyebrows.

"Yes! Its the Minerva Laboratories. Have you heard of it?" Sucrose asked enthusiastically.

Minerva.. MINERVA!?? ofcourse you've heard of it.

"Uh yes i have. Um.. well i think I'll pass, you both should go with Sucrose." You told them.

"Why won't you come along with us?" Shin-won asked.

"I.. I have some work to catch up on. I'll know the results afterwards, okay?" You said concealing the truth.

Jungkook gritted his teeth, "Y/n, we need to talk." He said that and grabbed your wrist and walked over to the balcony.

"Y/N, are you trying to avoid me?" He said after he let go off your wrist. Even though what he said was partially true, you knew better than anyone else about Jungkook's emotional swings- they were unpredictable nowadays.

You gulped, "Ningguang.. she works there. I- i just don't want to bump into her at all, i dont want to get reminded about Jimin.. so.. so i just want to stay away from everyone and everything that'll remind me of him."

Oh boy! Jungkook felt apologetic for misunderstanding you.. and at the same time his chest was swelling up from happiness.. you really wanted to stay away from Jimin? He loved how loyal you were to him.

He at once took you in a hug catching you off guard, "I knew it, you wouldn't betray me, you wouldn't break your promise." He breathed in the crook of your neck as he snuggled further in the hug.

You blinked rapidly with guilt once again stirring up in your heart, oh how you wish you could turn back time and stop all of this from happening!

You sighed, "Now that you know.. you all should hurry up and go."

Jungkook hummed in your hug.

--

Jungkook and Shin-won sat outside the lab since morning.. and it was evening right now, naturally Jungkook was growing reckless, just how long will he stay here? Any place without you feels like absolute hell to him.

He wants to go back home, to you.. because you were his home, you were the person who brings peace to his mind, you were the one he would call his, you were the one he belonged to.

His thoughts were interrupted once Sucrose swung open the door, "guys, here's the report and my conclusion at the bottom.. i hope this will help you guys work things out." She said with a hint of worry on her face.

Shin-won took the two reports from her hands and Jungkook looked over the details beside him.

"What?!" Shin-won couldn't believe the conclusion he just read.

"The dose works perfectly fine, no issues found.

1. Mr. S has shown no abrupt signs and the antidote has worked well. Mr. S has likely shown infatuation towards Ms. Y but it can be interpreted that way due to high dose of loveshot.

Antidote has ceased the symptoms.

2. Mr. J has shown strong infatuation towards Ms. Y with the antidote failing to cease the symptoms even after 5 days of taking the antidote twice.

Conclusion

Mr. J has strong feelings towards Ms. Y and the dose has likely caused the dormant feelings to display.

It can thus be concluded that the dose has amplified the feelings therefore sticking to it's main objective of- "even if there's slightly any love/infatuation, the loveshot will trigger those particular emotions."

Shin-won's face grew pale, "Jungkook, what does all of this mean? You like Y/N.. no.. you more than just like her, don't you?"

Jungkook bit his lower lip, "I guess so."

Shin-won shook his head, "Why didnt you say so when i was injecting the shot? Why didn’t you tell me?"

Jungkook sighed, "I was afraid that you might slip it up to Y/n before i even had a chance.. tell me, would you not tell her?"

Shin-won blinked, "um.. i- i think?"

Jungkook scoffed, "look at this kid." He playfully smacked Shin-won's head, "Now that we know, i just wanna go home and take some rest. You should go to your home as well and we'll rack our brains tomorrow."

"Wait! What's the rush? You are dying to see Y/n.. aren't you?" He wriggled his eyebrows, "stop with that, fine.. yes, i am dying to meet her, happy?"

"Dont tell me you're obsessed with her." He said nonchalantly while keeping the reports inside his bag.

Obsessed?

It seems like Jungkook has finally realized the feelings which had stayed dormant towards you, now that he thinks about it.. Jungkook indeed used to look out for you everytime even before the loveshot came in the scenario.

He was interested in everything you did, he noticed even the smallest of details about you that might go unnoticed by everyone else. He was always curious about you.

Always.

Upon not hearing any answer, Shin-won finally looked up from his bag towards Jungkook, he blinked, he wished to hear a no from Jungkook, he really did.. so he asked again, "Are... you.. obsessed with her?"

Jungkook's face morphed in a twisted look, "I need some time to think about it."

With that said, he walked away leaving Shin-won behind.

Jungkook was trying to add things up, the more he thought about this.. the more he felt ridiculous about himself.

Was it really not the loveshot that caused him to be so attached to you? Was he always like this? Jungkook ran his hand through hair, he just can't believe it.

He thought he loved you.. he loves you, he's sure of it, but.. "ugh! I need to see her right now." He drove his car as fast as he could.

When he reached your apartment, to his surprise the door was unlocked.

"Y/n?" He called out your name. He didn't hear you answer so he went inside and searched every room.

Did you go outside? He hurriedly dialed your number, he heard your mobile ring in the next room but you weren't there. Where could you have gone without your phone? Did you forget to take it? Or has something happened to you?

Just as Jungkook was stepping out of the main door, he received a notification.

"Whose number is this?" He looked at the unknown number in frustration from not finding you.

He clicked on the message.

xxx-xxx-912 : hey man, it's me! Jimin.

xxx-xxx-912 : you wanted the update right, here you go!

And there lied an image attachment of Jimin and you making out.

*clears throat* ehe what's going on!? 👀

[rupalic]

Growth Strategies Adopted by Major Players in Turf Protection Market

In the dynamic landscape of the turf protection industry, key players like Syngenta Crop Protection AG (Switzerland), UPL Limited (India), Corteva Agriscience (US), Nufarm (US), Bayer AG (Germany), and BASF SE (Germany) are at the forefront of innovation and market expansion. These industry leaders are driving growth through strategic initiatives such as partnerships, acquisitions, and cutting-edge product developments, solidifying their positions as influential forces in shaping the future of the turf protection industry. Their efforts not only enhance their global presence but also set new benchmarks for industry standards and customer expectations. The global turf protection market size is estimated to reach $8.1 billion by 2028, growing at a 4.9% compound annual growth rate (CAGR). The market size was valued $6.4 billion in 2023.

Top Global Turf Protection Leaders to Watch in 2024

· Syngenta Crop Protection AG (Switzerland)

· UPL Limited (India)

· Corteva Agriscience (US)

· Nufarm (US)

· Bayer AG (Germany)

· BASF SE (Germany)

· SDS Biotech K.K. (Japan)

· AMVAC Chemical Corporation (US)

· Bioceres Crop Solutions (Argentina)

· Colin Campbell (Chemicals) Pty Ltd (Australia)

· ICL Group Ltd. (US)

Investments and Innovations: Key Strategies of Top Turf Protection Companies

🌱 Syngenta Crop Protection AG: Leading the Way in Integrated Pest Management

Syngenta Crop Protection AG, a global agribusiness based in Switzerland, operates prominently in the crop protection and seeds markets. The company offers a comprehensive range of herbicides, insecticides, fungicides, and seed treatments, helping growers worldwide enhance agricultural productivity and food quality. With a presence in over 90 countries, Syngenta’s reach is truly global. In October 2020, Syngenta further strengthened its position by acquiring Valagro, a leading biologicals company. Valagro’s strong presence in Europe, North America, Asia, and Latin America complements Syngenta’s existing crop protection chemicals. This acquisition allows Syngenta to offer more integrated pest management strategies that reduce reliance on synthetic chemicals, while Valagro’s expertise in plant nutrition promotes healthier turfgrass growth and improved soil health.

Know about the assumptions considered for the study

🌍 UPL Limited: Innovating Turf Management Solutions Globally

UPL Limited, formerly known as United Phosphorus Limited, is a global agrochemical company based in India, providing a wide range of agricultural solutions, including crop protection products, seeds, and post-harvest solutions. UPL is a key player in turf management, offering innovative solutions for golf courses, sports fields, and other turf areas. Their product portfolio includes herbicides, fungicides, insecticides, and plant growth regulators, all designed to enhance turf quality and health while effectively controlling pests and diseases. Operating in over 130 countries across North America, South America, Europe, and Asia Pacific, UPL has 28 manufacturing sites worldwide, solidifying its position as a leader in the global turf protection market.

🏆 Bayer AG: Streamlining for a Focused Future in Turf Protection

Bayer AG, a multinational pharmaceutical and life sciences company headquartered in Leverkusen, Germany, operates across three business segments: Pharmaceuticals, Consumer Health, and Crop Science. The company’s Crop Science division caters to the turf protection market, offering products such as herbicides, insecticides, and fungicides. With operations in over 90 countries, including regions like North America, South America, Europe, the Middle East, Africa, and Asia Pacific, Bayer maintains a strong global presence. In March 2022, Bayer sold its Environmental Science Professional business, which includes turf protection products, to private equity firm Cinven for USD 2.6 billion. This strategic divestment is part of Bayer’s ongoing efforts to streamline its portfolio and concentrate on core businesses, ensuring a more focused approach to its future operations.

[justinspoliticalcorner]

Samantha Riedel at Them:

The Trump campaign has been building out “Agenda47” into a 20-point platform — explained in a series of videos on the campaign site — since late 2022. Most of the component planks deal with perennial Trump scapegoats: Chief among Trump’s priorities, for example, is bringing an end to what he calls the “migrant invasion,” partly via a massive deportation campaign. Two “Agenda47” policies target LGBTQ+ people in particular, specifically transgender people, with Trump promising to wage war on “radical gender ideology” in schools and also “keep men out of women’s sports.”

Republicans have eagerly latched on to trans women athletes as a wedge issue in recent years, asserting that trans women have biological athletic advantages over cis women (despite a lack of evidence for such claims). In a February 2023 message decrying “left wing gender insanity,” Trump affirmed that if elected, he would interpret the federal anti-discrimination statute Title IX to entirely prohibit trans women from participating in women’s sports, and ask Congress to pass legislation to affirm that interpretation. Although President Joe Biden introduced new trans-inclusive rules for interpreting Title IX during his term, those changes applied to trans students in all areas except athletics (and are currently blocked pending litigation in federal court).

But Trump’s anti-trans plans aren’t limited to sports. His February 2023 proclamation stated that he would seek a federal definition of “gender” that is restricted to only “male and female” as assigned at birth. Trump also vowed to ban gender-affirming care for trans youth, falsely labeling such medical care “mutilation” and “mutation” and promising to terminate trans-affirming doctors from Medicare and Medicaid. In his Agenda47 video, Trump falsely claimed that trans people and gender dysphoria did not exist “until the radical left invented it just a few years ago.” He also accused pharmaceutical companies of pushing hormone therapy, puberty blockers, and surgeries for profit, but provided no evidence of such a conspiracy. “Under my leadership, this madness will end,” Trump concluded in the video.

Much of Agenda47’s anti-trans language dovetails with Trump’s anti-teacher and anti-education positions, representing a series of attacks not just on queer and trans students, but on teachers and educators who do not adhere to the Republican party line. At various points, Agenda47 describes schools as “indoctrinating” students with “Marxism,” “critical race theory,” and “gender ideology.” Trump’s solutions to the imagined problem would include monetary rewards for schools who strip K-12 teachers of their tenure; a federal “Parents Bill of Rights,” likely with similar language to anti-LGBTQ+ state bills of the same name; a Red Scare-like hunt for “the radicals who have infiltrated the federal Department of Education”; and a new teacher certification board to ensure educators “embrace patriotic values.” Trump is also heavily courting conservatives who homeschool their children, a longtime Republican pet project that has rapidly gained ground in recent years. The Trump team has insisted that their candidate has nothing to do with the now-infamous Project 2025, despite its breathless ambition towards “institutionalizing Trumpism” (and Trump’s close ties with its architects). But Agenda47’s policy items are near-indistinguishable from Project 2025’s, making the difference largely a matter of branding. As Ms. magazine noted, Project 2025 also seeks an end to federal protections for trans people at any level, diametrically opposes Biden’s reinterpretation of Title IX, and would establish a “male/female” gender binary on the federal level, even prohibiting school officials and educators from using a trans student’s pronouns. Where the Heritage Foundation-organized document differs from Trump’s anti-LGBTQ+ platform, it is in its discussion of marriage: While Trump avoids the topic of gay marriage, Project 2025 confidently states that “married men and women are the ideal, natural family structure.”

The policy agendas of both Agenda 47 and Project 2025 regarding LGBTQ+ (and especially trans rights) are major concern, should Donald Trump get back into office.

While there is significant overlap between Heritage’s Project 2025 and Trump’s Agenda 47, both have slightly different priorities regarding the LGBTQ+ issue, whereas A47 deemphasizes opposition to marriage equality and P2025 embraces it.

[mariacallous]

It’s been hard recently to think about anything other than the wars and humanitarian crises raging around the world. Climate change has left its mark in what was almost certainly the hottest year in human history—there were unprecedented heat waves, intensified forest fires, torrential rain, and floods like those in Libya that caused devastation after two dams burst.

But this has not stopped scientists, innovators, and decisionmakers from working on solutions to our biggest societal challenges—with success. Here is a collection of uplifting news to come out of 2023.

A powerful laser veered lightning strikes off their path

In an instant, millions of volts can damage buildings, spark fires, and harm people—unless the lightning can be redirected. An experiment with a laser beam suggests this is possible. The scientists behind it must now demonstrate that their multimillion-dollar laser would actually work better at critical sites such as airports and rocket launchpads than widely used, cheap lightning rods. Read more at Science.

Asteroid rocks and dust were brought to Earth

The first US mission to collect an asteroid sample, OSIRIS-REx, successfully returned a capsule containing granules and dust from the asteroid Bennu. Early analyses back at NASA’s lab suggest the sample is rich in carbon and water-laden minerals, the building blocks of life on Earth. Read more at WIRED.

Scientists grew mouse embryos for the first time ever in space

What would make humans a truly spacefaring species? If we could reproduce and grow outside of Earth’s atmosphere. It may be that this is possible, an experiment with mice suggests. Scientists managed to grow mouse embryos aboard the International Space Station and return them safely to Earth. Their initial growth appeared to be unaffected by the low gravity and high radiation. Read more at New Scientist.

A rare egg-laying mammal was rediscovered after decades

A species with the spines of a hedgehog, the snout of an anteater, and the feet of a mole seems hard to miss. But the long-beaked echidna Zaglossus attenboroughi—named after British naturalist David Attenborough—had remained hidden until caught on camera for the first time since it was scientifically recorded in 1961. This egg-laying mammal is known to only live in the Cyclops Mountains in the Indonesian province of Papua. Read more at Mongabay.

Countries signed a landmark treaty to protect the high seas

After almost 20 years of negotiations, members of the United Nations agreed to protect marine life in international waters—the two-thirds of the world’s oceans that lie outside of national boundaries. This legal framework enables, for example, the creation of vast marine protected areas (MPAs). It also states that “genetic resources,” such as materials from animals and plants discovered for use in pharmaceuticals or foods, should benefit society as a whole. Read more at The Guardian.

California national park bounces back after wildfire

Two years after California’s largest single wildfire burned almost 70 percent of Lassen Volcanic National Park, the ecosystem remains viable. Shrubs and grasses are growing in burned areas while fungi and insects are decomposing dead tree trunks, leading to a slow recovery. Read more at The Guardian.

Brazil’s top court rules for Indigenous rights in landmark case

A powerful agribusiness lobby tried to place time limits on Indigenous peoples’ right to land. They would have to prove they lived on the land in 1988, when Brazil’s current constitution was ratified. But many Indigenous peoples were expelled from their ancestral lands during the country’s military dictatorship, which lasted from from the 1960s to the 1980s. The Supreme Court in Brazil squashed the proposed time limit for land claims. Read more at AP News.

There could be a large reserve of hydrogen deep beneath the French ground

Hydrogen could power factories, trucks, ships, and airplanes in the future—but producing it requires a lot of energy and is expensive. But the gas also occurs naturally deep in the Earth’s crust, and researchers in France have accidentally stumbled on a potentially large deposit. Next year they plan to begin drilling to collect gas samples from depths of up to 1.8 miles. Read more at the Conversation.

The world may have crossed a solar power tipping point

A new study suggests that solar is on track to become the main source of the world’s energy by 2050—even without more ambitious climate policies being introduced. Renewables are already cheaper than fossil fuels. But in the case of solar energy, obstacles such as integration into electricity grids and financing in developing countries still need to be overcome in order for it to continue to grow as it has in recent years. Read more at the Conversation.

A new type of geothermal power plant is making the internet a little greener

A pilot plant is now helping to power Google data centers in Nevada by harnessing the Earth’s heat deep beneath it. Engineers drilled two boreholes down 7,000 feet, and then connected them by fracking, a technique that’s conventionally used in the oil and gas industry. Water sent down one borehole moves through the fracked rocks below and returns to the surface heated up via the other drilled hole. Read more at WIRED.

World’s first container ship powered by methanol completed its maiden voyage

Laura Maersk, the world’s first methanol-fueled ship, arrived in England in September—a milestone for the shipping industry, which is responsible for about 3 percent of worldwide emissions and struggling to decarbonize. Methanol can be made from food waste at landfills. Read more at the BBC.

A cheap and effective vaccine against malaria got approval

There’s now a second malaria jab that could be produced even quicker than the first and rolled out to more children. It got the thumbs up from the World Health Organization in October, two years after the first one. Malaria is the leading cause of death among children in sub-Saharan Africa. Read more at Stat News.

The largest study of migraine sufferers promises new treatment pathways

In the largest genetic study of migraines to date, researchers have identified more than three times the number of genetic risk factors previously known. This will help to better understand the biological basis of migraines and their subtypes and could speed up the search for new treatments. Read more at Science Daily.

Scientists made breakthrough in cervical cancer treatment

In a UK trial of 500 women, half received existing, cheap drugs before standard radiotherapy. The results showed that with the combined therapy, women’s risk of death or relapse fell by 35 percent. According to the researchers, this is the biggest improvement in treating this disease in over 20 years. Read more in the Independent.

Gene therapy showed early promise for children

Scientists in China reported that some children who were born deaf could hear after a gene therapy trial. Meanwhile, experiments are underway in the USA and France aimed at children with a rare form of genetic deafness. Read more at WIRED.

An implant restored walking ability for Parkinson’s patient

A man with advanced Parkinson’s disease can walk several miles again thanks to a special implant. Positioned in the lumbar region of the spinal cord, the implant sends electrical signals to his leg muscles. The scientists behind the innovation plan to carry out further trials with other patients in the coming year. Read more at SWI swissinfo.ch.

DeepMind’s new AI can predict whether a genetic mutation is likely to cause disease

Researchers at DeepMind, Google's AI company, have trained an AI model to detect DNA mutations, which could speed up the diagnosis of rare diseases. Similar to language models like ChatGPT, this model knows the sequences of amino acids in proteins and can detect anomalies. Read more at WIRED.

AI-powered prediction helped Chileans evacuate from floods

A forecasting tool from Google can predict floods in South America and other regions using a little data on the water flow of rivers, with impressive accuracy. This August, many people in Chile were able to evacuate safely and with their belongings thanks to a warning sent out two days before the flooding. Read more at Fast Company.

The Hollywood actors’ and writers’ battle against AI ended—for now

Generative AI has made it to Hollywood, and after months of strikes, both the writers and actors unions managed to negotiate guardrails on how the technology can be used in film and TV projects. AI cannot, for example, be used to write or rewrite scripts, and studios are not allowed to use scripts to train AI models without the writers’ permission. Read more at WIRED.

Lego bricks are teaching kids Braille

The iconic studs on the Lego bricks allow them to be stacked on top of each other. And now you can learn a new language while you’re at it. The company has started selling bricks with modified amounts of studs that teach the Braille alphabet. The corresponding letter or number represented by a brick’s studs are printed on each brick so that children can learn the code. Read more at TechCrunch.

[callsign-owl]

Ignorance is Bliss

Trigger Warning: Drugs, Alcohol

Ever since Owl has been a teenager, drugs and alcohol have been a major part of how he deals with his issues. Owl will choose to escape reality for a while instead of actually facing his problems. Additionally it is also a way he self-medicates his ADHD and autism subconsciously.

If you can think of it, Owl has probably tried it. He also has absolutely no qualms to use his medical knowledge to get high in the easiest and most efficient ways possible (his knowledge of pharmaceuticals is quite extensive). Owl has experimented around a lot over the course of his life and mixed things you‘re definitely not supposed to mix (and continues to do so). He always claims he knows what he is doing. Which yes, most of the time he knows exactly what he is doing and he is very well aware how reckless and dangerous it is and will choose to do it anyway, despite knowing about the potential consequences. All just to feel better for a while.

Owl also claims that he has everything under control and that it is not a problem. He would never consider himself an addict even though a lot of his behaviour does fit the diagnostic criteria. Despite his reckless and irresponsible behaviour he does limit it to his free time and he would absolutely never jeopardize a mission or anything of that sort.

Some people had hoped that joining the military would finally teach Owl some healthier coping mechanisms and force him to stop. While his behaviour has definifely improved a little bit, Owl will still resort to doing what he knows works for him. He knows it‘s not a solution but he also knows it will make him feel better at least for a little while.

[dontmeantobepoliticalbut]

Gov. Jeff Landry signed into law Tuesday a bill allowing executions by nitrogen gas and electrocution, opening the door for Louisiana to revive capital punishment 14 years after it last used its death chamber.

Landry signed the legislation, House Bill 6, and 10 other bills into law while surrounded by crime victims' loved ones and law enforcement officials in a ceremony at the State Capitol. HB 6 also shrouds records of the state's procurement of lethal injection drugs in secrecy, a step supporters say will make it easier to obtain those drugs.

The death penalty bill headlined a slate of tough-on-crime legislation approved by the Republican-controlled state Legislature last month and championed by Landry, a Republican and former state attorney general who campaigned on a promise to punish criminals and uplift people affected by violent crime. The new laws reverse a path charted by the state's 2017 Justice Reinvestment Initiative by slashing chances for convicted criminals to be released from prison early and lengthening sentences for some crimes.

"This is what I ran on," Landry said Tuesday.

The Governor also signed bills that allow people to carry concealed handguns without permits, eliminate parole for adults who commit crimes after Aug. 1, dramatically cut the availability of good behavior credits in prison and limit how people can request plea deals after their convictions, among others.

Landry is expected to sign additional bills passed in last month's special session in New Orleans on Wednesday, including measures to publish court minutes for youth accused of violent crimes, increase penalties for carjacking and weapons offenses and give Landry more control over the state's public defense system.

Protests against that legislation — particularly the death penalty bill, which opponents caution promotes one method that has hardly been tested and another ruled inhumane by courts in some states — spurred fiery debate but did little to sway lawmakers, most of whom fell in line with Landry's agenda.

A series of criminal justice advocacy groups spoke out against the new laws again on Monday, saying they will do little to curb crime and risk bloating the state's prison population to pre-2017 levels.

The 2017 public safety laws, which drew bipartisan backing and support from law enforcement, released people with convictions for nonviolent crimes and saved the state some $153 million, a recent audit found.

"Blaming the wrong problems doesn’t get the right solutions, and our communities for years have made clear the solutions necessary to address the very real concerns and needs of all Louisianans," said Danny Engelberg, the chief public defender in New Orleans. "These misguided bills will balloon our already bloated legal system, jails and prison system, and further widen the inequities in justice, safety, and community well-being."

The first modern execution by nitrogen gas occurred in Alabama in January. It sparked pushback from anti-death penalty advocates who expressed concern about eyewitness reports that Kenneth Smith, who was put to death for a 1988 murder-for-hire, writhed and struggled for air for some 20 minutes after nitrogen began flowing into his mouth. Alabama officials said the execution was humane and offered to aid other states' efforts to put the method to use.

Difficulty obtaining the cocktail of execution drugs from pharmaceutical firms, along with former Gov. John Bel Edwards' opposition to capital punishment and a series of federal court orders pausing executions in recent years, had kept Louisiana from putting anyone to death since 2010.

It's unclear when state officials might begin taking steps to obtain materials needed to carry out executions or when executions could resume in Louisiana. Also unclear is which of the three execution options the state will use; the new law leaves that choice to the secretary of the state's Department of Public Safety and Corrections.

HB 6's sponsor, Rep. Nicholas Muscarello, R-Hammond, said in an interview last month that Landry has indicated that his preferred execution method is lethal injection.

Last week, a DPSC spokesperson referred questions about the death penalty process to Landry's office, which did not respond to requests for comment. Landry left Tuesday's bill-signing ceremony without taking questions from reporters.

The new law letting people carry concealed handguns without permits, which supporters dub "constitutional carry" because they argue it restores an absolute right to self-armament enshrined in the United States' founding document, drew applause from gun rights activists and condemnation from gun safety groups.

National Rifle Association Interim CEO Andrew Arulanandam in a statement praised the "resolve" of Landry and "pro-self-defense legislators" who voted for the new law. Angelle Bradford, a volunteer for the Louisiana chapter of the pro-gun control group Moms Demand Action, criticized Landry for "cater(ing) to the gun lobby and reinforc(ing) their deadly ‘guns everywhere’ agenda."

[ofthefog]

I think when you ask "Why does this job exist even though it seems bullshit? Why does that job exist even though it seems bullshit?" the answers are probably wildly different depending on the specific job you are talking about. Maybe, maybe when you answer this for a lot of jobs, a pattern will emerge within the answers. But this abstract pattern has to come after the concrete answers. When you're rushing for the big theory, you are bound to miss a lot.

If we're talking about me then the question I asked was why do some workplaces expect you to get drunk with your cohort after hours, even being penalized if you don't go along with it.

I didn't expect to become Graeber's strongest soldier over here, especially since I think there is plenty to criticize when it comes to Bullshit Jobs. I think it's irresponsible to throw out numbers and percentages of the entire workforce, for one.

But the thing the book does best is getting you asking more questions. Calling it curiosity killing is literally the worst criticism you can make.

Now in the article, Graeber does not make this distinction but in the book he does make 5 categories of bullshit jobs

Flunkies, the reported purpose of which is to inflate the ego of the hirer.

Goons, in the sense of a villain, lobbyists, corporate lawyers. The idea being that if the corporation just did right on its own it wouldn't need these.

Duct tapers, jobs about doing routine maintenance that could easily be replaced by a permanent solution.

Box tickers, who can list a series of tasks they have done that have the appearance of work but which ultimately doesn't amount to anything.

Taskmasters, who are the ones making the tasks that ultimately don't amount to anything

The example of a flunky was that of a store greeter. This is actually very convenient because Walmart had a period from 2012 to 2016 where they got rid of greeters. That they brought them back is an interesting start.

Apparently there was a 35% reduction in shrinkage in stores that had walmart greeters according to a 2015 study published in the Journal of Applied Security Research, but I couldn't find this. Coupled with the expanding security role with the pandemic and mask wearing, and more requirements to lift things it seems like by Graeber's own standards this is a position that is getting saddled with more and more real work. I figure there may be a generic assistant type that fits this as an entire role, but mostly this exists as a portion of time in a role that does things for real sometimes.

For corporate lawyers, I'm no expert on the matter so what I can say is fairly limited. Obviously corporations should have some interface with the law so they can proceed lawfully. The existence of lobbying is something that has a societal cost but it very much makes economic sense for a specific company to do because it makes them more money. I suppose that if lobbying didn't exist at all then things could be easier, but we can say the same about security. Because as soon as there is no security it suddenly is apparent why it was necessary.

Duct tapers is what pharmaceutical companies get touted as being, where they sell maintenance when they should be looking for a cure. If I recall correctly there was an analysis looking at cuban medical care versus the US and there wasn't much difference except in eye care? So this can be a weak positive. Maybe a better example is getting fucked over by a car mechanic.

Box tickers is more of an aspect of a job rather than a job itself which is why I think it is one of the stronger points. The classic example is This Meeting Could Have Been an Email.

But I think that brings up the interesting case of middle management.

Different industries require differing levels of complexity. You don't need a middle manager to come in between the family farm but you better have a solid line of command for the nuclear reactor.

Both under and over managerialization exists. Under takes the form of too many employees reporting to a single person. If 10 people all in their own specialization have a problem, there is no way that just a single person is not going to miss something.

From the employers perspective there is also the problem of turnover. It turns out that with high competition or even no capability for promotion and higher wages, people just start leaving. This is a good decision because workers who switch jobs tend to make more money.

The middle manager with higher pay can exist to reduce the cost of higher and training a new person to fill that role, and theoretically the employee can enjoy things like "job security" and "company culture".

Over looks like people getting promoted until they are too bad at their job to continue. But the thing is, hierarchies are sticky. If they stop being useful they don't dissolve, they rush to justify their existence. And that is precisely what happens with taskmaskers.

There are jobs which entirely consist of rubber stamping other people's work. It might have been necessary that a thorough inspection was necessary at one point, but everyone else is up to speed now. But you can't just go to your boss and say "hey I'm useless now, please don't fire me by the way".

There's multiple ways to deal with this situation. Job hopping as mentioned previously. Or you can take multiple jobs if the industry makes sense for it. Like these remote tech workers. ( notice how the fact it is abstract allows them to do this, but it is not the sole reason ). Or in worse cases, you can invent bullshit for people to do to pad out the real work to make it up to the hours you work on paper.

If we had to come up with a big narrative for the whole thing I suppose it would be the protestant work ethic. A concept with by no means was invented by Graeber.

Maybe if we actual could go to the boss and say hey I'm not doing real work right now without being extremely penalized for it, then this wouldn't happen.

And I think Graeber's suggestion of UBI would be helpful for doing that in practice. If people get a livable wage then it becomes a viable option to just not do work that you think is bullshit.

Hell, I reckon that if people had time and money outside of work they may even stop forcing their employees to party with them.

[arogyaaushadhi]

The Rise of Generic Medicine: A Revolution in Healthcare by Arogya Aushadhi

In the ever-evolving world of healthcare, the advent of generic medicine has been a game-changer, providing affordable and effective treatment options to millions around the globe. At Arogya Aushadhi, we are proud to be at the forefront of this revolution, offering a wide range of high-quality generic medicines that ensure both accessibility and reliability for our customers.

What Are Generic Medicines?

Generic medicines are drugs that are equivalent to brand-name medications in dosage, strength, route of administration, quality, performance, and intended use. They contain the same active ingredients and are proven to be just as safe and effective as their branded counterparts. The primary difference lies in the fact that generic medicines are typically sold at significantly lower prices.

The Benefits of Generic Medicines

Cost-Effective: One of the most significant advantages of generic medicines is their affordability. By bypassing the extensive marketing and research costs associated with brand-name drugs, manufacturers can offer generic versions at a fraction of the price. This makes healthcare more accessible, especially for those in lower-income brackets.

High Quality and Safety: Generic medicines must meet stringent regulatory standards set by health authorities like the FDA. At Arogya Aushadhi, we ensure that all our generic products are manufactured in state-of-the-art facilities and undergo rigorous quality control processes to guarantee their safety and efficacy.

Wider Accessibility: With the introduction of generic medicines, patients now have a broader range of treatment options. This is particularly beneficial in regions with limited access to healthcare, where the availability of cost-effective drugs can significantly improve health outcomes.

How Arogya Aushadhi Is Leading the Way

At Arogya Aushadhi, we believe that everyone deserves access to high-quality healthcare. Our commitment to excellence is reflected in our extensive portfolio of generic medicines, which covers a wide array of therapeutic categories. From pain management to chronic disease treatment, our products are designed to meet the diverse needs of our customers.

Branded Generics: We offer a range of branded generic medicines that combine the trust and reliability of brand-name drugs with the cost benefits of generics. Each product is meticulously crafted to ensure optimal performance and patient satisfaction.

Nutraceuticals and Ayurveda: In addition to conventional medicines, Arogya Aushadhi also provides a variety of nutraceuticals and ayurvedic products. These natural supplements and remedies are designed to promote overall health and well-being, offering holistic solutions for various health concerns.

Baby Care Essentials: We understand the importance of providing safe and effective healthcare products for the youngest members of our community. Our baby care essentials include a range of generic medicines and products that cater to the unique needs of infants and young children.

The Future of Generic Medicine

As the global demand for affordable healthcare continues to rise, the role of generic medicines will become increasingly crucial. Innovations in pharmaceutical research and manufacturing are set to further enhance the quality and efficacy of these drugs, making them an indispensable component of modern healthcare.

Conclusion

The impact of generic medicines on global healthcare is undeniable. By offering cost-effective, high-quality alternatives to brand-name drugs, they have transformed the landscape of medical treatment, making it more accessible and equitable. At Arogya Aushadhi, we are dedicated to advancing this mission, providing a comprehensive range of generic medicines that cater to the diverse needs of our customers. As we look to the future, our commitment to excellence and innovation will continue to drive us forward, ensuring that everyone has access to the healthcare they deserve.

[soniez]

India's Pharma Industry – The Leading Companies You Need to Know

India's pharmaceutical industry stands as a global powerhouse, contributing significantly to the world's supply of medicines and pharmaceutical products.  The country's ability to produce high-quality, affordable medicines has earned it the title of "Pharmacy of the World."  As the industry continues to grow and innovate, several companies have emerged as leaders in the market.  For Centurion HealthCare Pvt. Ltd., understanding the landscape of the top pharma companies in India provides insights into the key players driving the industry's success.

The Rise of the Pharmaceutical Industry in India

The pharmaceutical industry in India has seen exponential growth over the past few decades.  From generic drug manufacturing to complex biotechnological innovations, Indian pharma companies have made substantial contributions to global healthcare.  This growth can be attributed to several factors, including a skilled workforce, robust research and development infrastructure, and supportive government policies.

Key Players in India's Pharma Industry

The landscape of the pharmaceutical industry in India is populated by numerous companies, each contributing to various segments of the market.  Here are some of the top pharmaceutical companies in India that are leading the charge:

1.   Sun Pharmaceutical Industries Ltd.

As the largest pharmaceutical company in India, Sun Pharma is renowned for its diverse product portfolio, including generics, branded generics, specialty medicines, and active pharmaceutical ingredients (APIs).  The company has a significant global presence and continues to expand its footprint through strategic acquisitions and partnerships.

2.   Dr. Reddy's Laboratories

Dr. Reddy's is a major player in the global generic pharmaceutical market.  Known for its strong focus on research and development, the company offers a wide range of pharmaceuticals and biotechnology products.  Their commitment to quality and innovation has solidified their position as one of the best pharmaceutical companies in India.

3.   Cipla Ltd.

Cipla has been at the forefront of providing affordable medicines for over eight decades.  The company specializes in respiratory, cardiovascular, anti-retroviral, and anti-infective therapies.  Cipla's dedication to healthcare accessibility and its significant contributions to global health initiatives make it a top pharmaceutical company in India.

4.   Lupin Limited

Lupin is a leading pharmaceutical company known for its focus on complex generics and specialty drugs.  The company's strong presence in both developed and emerging markets has earned it a place among the top 10 pharmaceutical companies in India.  Lupin's investment in R&D and its broad therapeutic portfolio are key drivers of its success.

5.   Aurobindo Pharma

Aurobindo Pharma is recognized for its extensive range of generic formulations and APIs.  The company's robust manufacturing capabilities and strategic global presence have made it one of the top pharmaceutical companies in India.  Aurobindo's commitment to innovation and quality continues to propel its growth.

6.   Zydus Cadila

Zydus Cadila, a leading pharmaceutical company, offers a wide range of healthcare solutions, including small molecules, biologics, biosimilars, and vaccines.  The company's integrated operations and strong research capabilities have established it as a key player in the pharma industry in India.

7.   Glenmark Pharmaceuticals

Glenmark is a global research-led pharmaceutical company known for its focus on innovation in the fields of dermatology, respiratory, and oncology.  The company's strong pipeline of new chemical entities and biosimilars underscores its position as one of the best pharmaceutical companies in India.

8.   Torrent Pharmaceuticals

Torrent Pharma is a major player in the cardiovascular and central nervous system therapeutic areas.  The company's strategic acquisitions and focus on niche segments have helped it become one of the top pharmaceutical companies in India.  Torrent's commitment to quality and patient-centric approach is evident in its product offerings.

9.   Biocon Ltd.

Biocon is India's largest biopharmaceutical company, specializing in biologics and biosimilars.  The company's focus on affordable innovation and its significant contributions to chronic disease management make it a leader in the pharmaceutical industry in India.  Biocon's global partnerships and strong R&D capabilities are key to its success.

10. Cadila Healthcare (Zydus)

Cadila Healthcare, also known as Zydus, is a prominent player in the Indian pharma industry, offering a wide range of healthcare solutions.  The company's innovative approach and comprehensive product portfolio have positioned it among the top 10 pharmaceutical companies in India.

The Role of Pharma Manufacturing Companies in India

Pharma manufacturing companies in India play a crucial role in the global supply chain of medicines.  These companies not only produce high-quality generics but also invest heavily in research and development to bring new and innovative drugs to the market.  The efficiency and scale of Indian pharma manufacturing are key factors in the country's ability to provide affordable medicines worldwide.

Finding the Best Pharma Companies Near You

For those searching for "pharma companies near me," it's important to recognize the regional presence of leading pharmaceutical companies.  Many top pharma companies in India have established manufacturing and research facilities in various parts of the country, ensuring widespread access to their products and services.

Centurion HealthCare Pvt. Ltd.  – A Leading Player in the Industry

Centurion HealthCare Pvt. Ltd. is an emerging name in the Indian pharmaceutical landscape.  As a medicine manufacturing company in India, Centurion HealthCare is dedicated to providing high-quality pharmaceutical products across various therapeutic categories.  The company's commitment to innovation, quality, and patient care positions it among the best pharma companies in India.

The Future of the Pharmaceutical Industry in India

The future of the pharmaceutical industry in India looks promising, with continued growth driven by innovation, increasing healthcare needs, and expanding global reach.  Indian pharma companies are expected to play a pivotal role in addressing global health challenges, developing new treatments, and ensuring the availability of affordable medicines.

Conclusion

India's pharmaceutical industry is a dynamic and rapidly evolving sector, with numerous companies leading the way in innovation, quality, and global healthcare contributions.  From established giants like Sun Pharma and Dr. Reddy's to emerging leaders like Centurion HealthCare Pvt. Ltd., the top pharmaceutical companies in India are making significant strides in improving healthcare outcomes worldwide.

As the industry continues to grow, these companies will remain at the forefront of pharmaceutical advancements, ensuring that India retains its position as a global leader in medicine production and innovation.  Whether you are looking for the best pharma company in India or seeking reliable pharmaceutical companies in India, the landscape is rich with options that exemplify excellence and commitment to health.

For Centurion HealthCare Pvt. Ltd., being part of this esteemed group of pharma companies in India is a testament to its dedication to quality, innovation, and patient care.  As the industry moves forward, Centurion HealthCare is poised to continue its growth and contribute to the global healthcare landscape, solidifying its place among the best pharmaceutical companies in India.

[antaxzantax]

Umbrella Pharmaceuticals - Chapter 34

He had chosen Raccoon City for its isolation, its poverty, its vibrant decadence. It was a wasteland, terra nullius[1]; a chimera, neither an industrial centre nor a small town in the foothills of the Appalachians. It was a want and I can't; a kind of American East End[2].

He landed there on the recommendation of a good old Californian friend. This friend, who knew of Oswell’s eternal desire to found his Motor City [3], recommended the Midwest because of its accelerated post-war boom. Cities such as Detroit had expanded relentlessly, and others such as Gary had sprung up like mushrooms. In the late 1950s, he opened the first Anzec Pharma plant in Detroit. Twenty years later, the Umbrella Pharmaceuticals plant closed due to the oil crisis of the early 1970s and the ongoing outsourcing of manufacturing to the Third World, a process Oswell hoped would be completed with Thatcher's impending election victory. Because of its terrible location and limited industrialisation, Raccoon City participated in the birth of the Rust Belt [4], becoming one of the few towns whose mayoralty was sold to foreign and domestic investors for four pounds. This attracted Oswell like a moth to a fly lamp. He took over the town hall and in less than five years, subverting the law, had his country house and training centre built. The financial boost he brought, in return for his guaranteed interference in the council, meant more jobs, more houses and more middle-class families happy with their bland lifestyles, less crime, fewer vagrants and well-fed bellies thanks to co-optation and bribery. In short, his plan had worked.

But there was another problem. The question of the Progenitor. It all fitted into the jigsaw of interpersonal relationships, favours and shell companies that would be used to carry out the second phase. With the approval of the City Council and the dismissal of the police, the disappearance of a handful of junkies, prostitutes, beggars and poor Whites, Blacks, Latinos and Asians would not attract attention if it was done with care and wisdom. He had already chosen his first “hotbed”: Eastside, the city's poorest area. A rattrap of dilapidated housing, half-ruined squats and caravan parks. Its residents struggled against the common ills of unemployment and drug addiction, the wilful incompetence of the authorities, the total neglect of the federal government and an unbearable desperation. In this situation, there was one problem: rats, and he proposed the solution: a fumigation company. They would either knock on the door or find an unsuspecting person driving a large, well-equipped van. The training centre was half an hour away. Sick, crippled or healthy: it didn’t matter. Marcus would process the “commodity” and some of it would be diverted to Spencer Mansion. If it worked, the next step would be Europe.

That was what had been agreed.

[1] Literally Latin for “no man's land”.

[2] The East End of London, often referred to within the London area simply as the East End, is the historic core of wider East London, east of the Roman and medieval walls of the City of London and north of the River Thames. The area was notorious for its deep poverty, overcrowding and associated social problems.

[3] Detroit's nickname, in the sense of an industrial and corporate city.

[4] The term "Rust Belt" refers to the impact of deindustrialization, economic decline, population loss, and urban decay on these regions attributable to the shrinking industrial sector especially including steelmaking, automobile manufacturing, and coal mining.

[weightlosscentrenearme]

Navigating the World of Weight Loss Supplements: Separating Fact from Fiction

In today's health-conscious society, the quest for an ideal body often leads many individuals to explore various avenues for weight loss. Among these options, weight loss supplements have gained popularity, promising quick and effortless results. However, before diving into the world of supplements, it's crucial to distinguish between evidence-based solutions and marketing hype.

Weight loss supplements are products designed to aid in reducing body weight through mechanisms such as appetite suppression, increased metabolism, or fat absorption inhibition. While some supplements have shown potential in limited studies, their effectiveness and safety vary widely.

One of the most well-known weight loss supplements is green tea extract, often praised for its thermogenic properties. Green tea contains compounds like catechins, which are believed to boost metabolism. Although research suggests that green tea extract may contribute to modest weight loss when combined with a healthy diet and exercise, it's important to note that the effects are generally small and may not lead to significant changes on their own.

Another frequently mentioned supplement is Garcinia cambogia, which contains hydroxycitric acid (HCA) and is claimed to suppress appetite and block fat production. However, the evidence supporting Garcinia cambogia's weight loss benefits is inconsistent, and more rigorous research is needed to validate these claims.

It's crucial to approach weight loss supplements with caution, as they are not regulated as strictly as pharmaceutical drugs. The lack of oversight can lead to variations in product quality, potency, and safety. Some supplements may even contain hidden ingredients that could have adverse effects on health.

Before incorporating any weight loss supplement into your regimen, consult a healthcare professional. They can help assess your individual needs and provide guidance on the most appropriate approach to achieving your weight loss goals. Remember that no supplement can replace a balanced diet and regular physical activity.

Moreover, keep in mind that sustainable weight loss is a gradual process that involves making long-term lifestyle changes. Relying solely on supplements may lead to disappointment and potential health risks. Instead, focus on creating a well-rounded routine that includes a nutrient-rich diet, regular exercise, proper sleep, and stress management.

In conclusion, the world of weight loss supplements is a complex landscape where scientific evidence often clashes with marketing claims. While some supplements may offer marginal benefits when used in conjunction with a healthy lifestyle, they should never be viewed as magic solutions. Prioritize informed decision-making and consult a healthcare professional before adding any supplement to your routine. Remember, the key to successful and sustainable weight loss lies in holistic approaches that prioritize overall health and wellness.

[chillersmanufacturer]

Efficient Cooling Solutions: Navigating Mumbai's Industrial Landscape with Water-Cooled Chillers

In the bustling industrial hub of Mumbai, where the relentless operation of machinery generates substantial heat, the need for effective cooling solutions has never been more critical. Among the diverse range of cooling technologies available, water-cooled chillers stand out as a reliable and efficient option. This article delves into the significance of water-cooled chillers in Mumbai's industrial context, highlighting their benefits, applications, and contributions to sustainable practices.

The Role of Water-Cooled Chillers: Water-cooled chillers play a pivotal role in maintaining optimal operating conditions for industrial processes by dissipating excess heat. In contrast to air-cooled alternatives, water-cooled chillers offer superior cooling efficiency, making them an ideal choice for the demanding requirements of Mumbai's industries. These chillers utilize water as a highly effective heat transfer medium, ensuring consistent and reliable cooling even in high-heat environments.

Advantages and Benefits:

Enhanced Efficiency: Water-cooled chillers boast higher efficiency compared to air-cooled systems, resulting in energy savings and reduced operating costs for industrial establishments.

Space Optimization: The compact design of water-cooled chillers allows for efficient space utilization within Mumbai's often limited industrial facilities.

Noise Reduction: Water-cooled systems are generally quieter than air-cooled counterparts, contributing to a more conducive working environment for employees.

Temperature Stability: With precise temperature control capabilities, water-cooled chillers ensure that critical processes are carried out consistently and efficiently.

Longevity: The use of water as a cooling medium helps extend the lifespan of equipment, reducing the frequency of maintenance and replacements.

Applications Across Industries: Water-cooled chillers find applications in various industries across Mumbai:

Manufacturing: Cooling machinery and equipment in industries such as textiles, chemicals, and automotive manufacturing ensures uninterrupted production and product quality.

Pharmaceuticals: Precise temperature control is crucial in pharmaceutical production, making water-cooled chillers indispensable for maintaining the integrity of sensitive substances.

Data Centers: As data centers proliferate, water-cooled chillers aid in preventing overheating of servers and ensuring reliable operations.

Food Processing: From refrigeration to maintaining hygiene during processing, water-cooled chillers contribute to safe and efficient food production.

Sustainability and Environmental Impact: In a time when sustainability is a global priority, water-cooled chillers offer significant environmental benefits. By reducing energy consumption and greenhouse gas emissions, these systems align with Mumbai's efforts towards a greener future. Additionally, water-cooled chillers can integrate with renewable energy sources, further enhancing their eco-friendly profile.

Conclusion: As Mumbai's industrial landscape continues to evolve, the role of water-cooled chillers remains paramount in ensuring efficient operations and sustainable practices. Their advantages in terms of efficiency, space optimization, and environmental impact make them a valuable asset across diverse industries. By embracing water-cooled chiller technology, Mumbai's industries can effectively navigate the challenges of heat management while contributing to a more sustainable and prosperous future.

[cedricfernandomd]

Unmasking the Alarming Rise: Prescription Pain Pill Overdoses Quadrupled in the Last Decade

Introduction

Prescription pain pill overdoses have become a silent epidemic lurking beneath the surface of our healthcare system. These overdoses have experienced a staggering quadrupling in numbers in the past decade, raising concerns and demanding urgent attention. This article aims to shed light on the alarming rise of prescription pain pill overdoses, examining the underlying factors, exploring the devastating consequences, and highlighting potential solutions to curb this alarming trend.

Unveiling the Statistics

The statistics are unequivocal: prescription pain pill overdoses have undergone an astonishing four-fold increase over the last ten years. According to recent data from the Centers for Disease Control and Prevention (CDC), the United States witnessed a sharp rise in overdose-related deaths, surpassing other forms of substance abuse. From 2010 to the present day, the number of lives claimed by prescription pain pill overdoses has skyrocketed, illustrating a crisis often overshadowed by the public's focus on illicit substances.

The Root Causes

Understanding the root causes of this disturbing trend is essential to addressing the issue effectively. Several factors contribute to the rise in prescription pain pill overdoses. Firstly, overprescribing practices have created an abundance of pills in circulation, leaving patients vulnerable to misuse or accidental overdose. Inadequate education among healthcare professionals regarding pain management alternatives and the risks of opioid medications has further exacerbated the problem. Additionally, the aggressive marketing strategies employed by pharmaceutical companies have fueled the widespread use of prescription pain pills, often leading to dependence and addiction.

The Human Toll

Behind the statistics lie the heartbreaking stories of individuals and families devastated by prescription pain pill overdoses. Lives are shattered, futures erased, and communities are left grappling with the aftermath. The victims of these overdoses come from all walks of life, dispelling the myth that this crisis is limited to a specific demographic. It affects people of all ages, races, and socioeconomic backgrounds. The impact extends beyond the immediate loss of life, as survivors and their loved ones face long-lasting physical, emotional, and financial consequences.

Combating the Crisis

Addressing the prescription pain pill overdose crisis requires a multifaceted approach. The medical community plays a crucial role in promoting responsible prescribing practices and educating patients about the risks and benefits of pain medications. Enhanced training programs should equip healthcare professionals with alternative pain management strategies, empowering them to offer comprehensive care. Stricter regulations regarding prescription monitoring programs and limiting pill quantities can help prevent excess pills from entering the black market.

Furthermore, public awareness campaigns are essential to inform individuals about the risks associated with prescription pain pills and encourage safer medication use. These campaigns should emphasize the importance of properly disposing of unused medications and promote alternative pain management options, such as physical therapy, cognitive-behavioral therapy, and non-opioid medications.

Collaboration between healthcare providers, policymakers, and pharmaceutical companies is vital to implementing effective policies and regulations. Pharmaceutical companies should be held accountable for their marketing practices and incentivized to develop safer, non-addictive pain management alternatives.

Conclusion

Over the past decade, the quadrupling of prescription pain pill overdoses has been a harrowing trend that demands immediate action. By addressing the root causes, amplifying public awareness, and implementing comprehensive strategies, we can strive to reverse this epidemic. Our collective responsibility is to protect the well-being of individuals and communities, ensuring that access to pain relief does not come at the cost of human lives. Only through concerted efforts can we hope to alleviate the burden of prescription pain pill overdoses and forge a healthier future.

[queen-street-news]

New Post has been published on https://bloornews.com/blog-toronto/misunderstanding-caused-bc-company-to-say-health-canada-licensed-it-to-sell-cocaine-trudeau-says/

‘Misunderstanding’ Caused BC Company to Say Health Canada Licensed It to Sell Cocaine, Trudeau Says

Prime Minister Justin Trudeau says it was a “misunderstanding” that caused a British Columbia-based company to say Health Canada granted it permission to produce, sell, and distribute cocaine.

Prime Minister Justin Trudeau speaks to the media in Ottawa on Feb. 12, 2023. (Patrick Doyle/The Canadian Press)

Trudeau told reporters in Winnipeg on March 3 that he was “as surprised” as B.C. Premier David Eby when he heard that the company Adastra Holdings Ltd., which produces marijuana for adult use and medical sales out of its headquarters in Langley, B.C., announced on Feb. 22 that it was permitted by Health Canada to “legally possess, produce, sell and distribute” cocaine.

The company said in a news release that it had been granted a Health Canada amendment to its controlled substance dealer’s licence on Feb. 17.

Eby first responded to the company’s statement on March 2, saying he was “astonished” that Health Canada would grant the amendment and that his government would be contacting Health Canada for answers.

“I was as surprised as the premier of British Columbia was to see that company was talking about selling cocaine on the open market or commercializing it,” Trudeau said on March 3.

“There are limited and very restricted permissions for certain pharmaceutical companies to use that substance for research purposes and for very specific narrowly prescribed medical purposes, but it is not a permission to sell it commercially or provide it on an open market.”

The prime minister said his government is actively addressing the issue.

“We are working very quickly with this company to correct their misunderstanding that their press release has caused,” he said, adding that decriminalizing the commercial sale of cocaine “is not something that this government is looking at furthering.”

Decriminalization B.C. decriminalized possession of up to 2.5 grams of certain hard drugs, including cocaine, beginning on Jan. 31 following Health Canada’s approval of three-year experimental decriminalization exemption program back in May 2022.

Federal Mental Health and Addictions Minister Carolyn Bennett has said that B.C.’s decriminalization plan will reduce “the stigma, the fear, and shame that keep people who use drugs silent about their use, or using alone.”

In 2022, B.C. had an average of over six people dying from drug overdoses every day, and over 11,000 people in the province have died from illicit drug overdoses since the provincial government declared a public health emergency in 2016.

Federal Conservative Party Leader Pierre Poilievre has criticized the decriminalization policy, saying the solution to the issue of addiction is “more treatment and recovery,” rather than “more poison.”

Both Trudeau and Justice Minister David Lametti have said Ottawa has no plans for a national drug decriminalization policy.

The Canadian Press and Marnie Cathcart contributed to this report.

(Patrick Doyle/The Canadian Press) Peter Wilson

[research-chem]

Synthetic-Chem Consulting Net

Here At Synthetic-Chem Consulting Network, you can buy Research Chemicals online at a reasonable price. We have the capabilities to serve everyone from home users to large businesses.  All of our Research Chemicals for sale can be purchased in quantities as little as 10 Grams and up to truckload quantities. 

where to get research chemicals online

Chemistry plays a pivotal role in the strength of the U.S. economy and the advancement of humankind. Chemists' achievements include life-saving pharmaceuticals, advanced energy solutions, improved agricultural productivity, and novel materials used in products from clothing to electronic devices. The many sectors reliant on the U.S. chemical economy account for about 25% of the U.S. GDP and support 4.1 million U.S. jobs. However, a new and evolving chemistry landscape requires changes with regard to funding, training, and a focus on integrating sustainability into manufacturing, product usage, and product disposal.

This report identifies strategies and options for research investments that will support U.S. leadership while considering environmental sustainability and developing a diverse chemical economy workforce with equitable opportunities for all chemistry talent. The report recommends that funding agencies and philanthropic organizations who support the chemical sciences fund as large a breadth of fundamental research projects as possible. Chemical industry and their partners at universities, scientific research institutions, and national laboratories should align the objectives of fundamental research to directly assist with new practices toward environmental stewardship, sustainability, and clean energy. Additionally, the report recommends that funding agencies make substantial investment toward education research to enable innovative ways of teaching about emerging concepts, tools and technologies.

National Academies of Sciences, Engineering, and Medicine. 2022. The Importance of Chemical Research to the U.S. Economy. Washington, DC: The National Academies Press.

To obtain research chemicals and controlled substances from the NIDA DSP, all research investigators will need to prepare a Request Package. A Request Package should include the following items:

1.  A cover letter including:

1.  Name, phone number and e-mail address of Research Investigator (and consignee, if applicable),

§  Provide a current and complete address that would allow shipment by a suitable carrier such as Federal Express (FedEx) (i.e. street address, building name or number, room number, city and state) - This address should coincide with the address on the DEA order form.

§  For radio-labeled drugs or chemical substances, indicate the address to which such materials will be shipped.  In case the shipping address is different from the researcher's address, a current copy of the radioactive materials license must be submitted.

2.  If applicable, NIH grant number of project and name and contact information of project’s NIDA/NIH Program Officer.  If a non-grantee, no information on Program Officer and grant number is required.

3.  Name(s) and quantity of compounds or other substances being requested,

§  The total radioactivity (preferred units of measurement, mg per vial, etc.)

§  If multiple studies/tasks are planned, combine projected needs into a single order rather than placing several separate requests in a short time interval. The request should generally be limited to four items or drugs/compounds per order to avoid delay.

§  Avoid drug abbreviations, and include specifications such as (+), (‑), (dl), base, or salt, as appropriate.  Please visit the NIDA Drug Supply Catalog (PDF, 11.6MB) (this document is not fully accessible, for help viewing this content, please contact Rik Kline at 301-827-5243), for drug supply information.

2.  The Research Investigator’s curriculum vitae (CV).

3.  A detailed research protocol clearly indicating:

1.  The specific aims and goals of proposed study (preferably the study abstract)

2.  The number of experiments and experimental subjects

3.  The dosages or concentration of drugs

§  Calculate required amount of drugs or chemical substances for your project and submit your request well in advance of your planned experiments or tasks, or 6‑8 weeks prior to depletion of stock on hand for ongoing studies/tasks.

4.  Justification of quantities of drug(s) requested.  If the request is related to a previously submitted protocol, provide a reference to this protocol and a brief statement of progress along with references to resulting publications.

4.  Statement of commitment that NIDA will be acknowledged in research publications using the NIDA Drug Supply Program.

5.  A completed DEA Order Form-222 for Schedule I-II controlled substances.

DEA Form-222 is not necessary for drugs in Schedules III‑V, but a valid registration for the appropriate schedule is required.

Under the third column of DEA Form-222 (Size of Package), list quantities as bulk weight. Radio-labeled compounds must be listed by weight and NOT by units of activity.

6. A copy of current DEA registration, Form DEA-223 for controlled substances.

It is the Research Investigator's responsibility to keep his/her registration current and to verify the drug code for requested drug.

Investigators who request a Schedule I drug and/or Etorphine HCl or Diprenorphine must provide DEA documentation under which the requested drug is covered under their current DEA registration.

Avoid drug abbreviations, and include specifications such as (+), (‑), (dl), base, or salt, as appropriate.

7. For radioactive compounds, a copy of Nuclear Regulatory Commission license.  For more information, please visit the Nuclear Regulatory Commission licensing website.

8. For clinical research projects involving human subjects

1.  Investigational New Drug (IND) number and a copy of approved IND letter from the FDA. For more information, please visit the FDA IND Application website. 

2.  A copy of your Institutional Review Board (IRB) approval letter ,

3.  A copy of your Data Safety and Monitoring Plan,

4.  Proof of registration with clinicaltrials.gov (NCT #)

5.  A copy of the study consent form(s)

9. For basic (non-human) research projects

1.  A copy of the document demonstrating that the research is approved by the Animal Care & Use Committee and that adequate care in conducting animal research will be exercised (if applicable).  For more information, please visit the Animal Care & Use Committee Animal Study Proposal website.

10. For ongoing research projects (This includes research previously supported by the NIH prior to request)

1.  Reference information1 pertaining the previous protocol / FDA approval to the previous protocol

2.  A brief statement of progress (500 words or less)

3.  A list of any relevant publications.

11. Billing Information for Shipping Costs:

1.  US investigators should provide their FedEx account number to bill shipping charges,

2.  International requests for controlled compounds should provide their United Parcel Service (UPS) Supply Chain Solutions account number to bill shipping charges. For non-controlled compounds the investigator should provide their FedEx account number.

12. For Foreign Investigators, please submit the Import Permit (preferably in English) issued by an appropriate agency of your government if the request is for an internationally controlled drug substance. The name of the supplier on the import permit must be listed as follows:

Research Triangle Institute Kenneth S. Rehder Ph.D. Hermann Building , East Institute Drive P.O. Box 12194 Research Triangle Park, NC 27709, USA

The import permit should be accompanied by a signed statement from the investigator to the effect that the drug will be used solely for the purpose of research and will not be re-exported. The import permit must contain a clear address and individual name to which the requested drug is to be delivered (not a post office box number). Shipment should be indicated on the import permit as Air Freight to this individual. Specify the appropriate port for customs clearance purposes and provide the name and address of the Customs Clearance Agent, if one is used.

Please obtain the longest possible expiration date on import permits.

Foreign investigators requesting drugs or other substances that are not very stable should be certain to make advance arrangements that would allow these drugs or other substances to be released to them expeditiously. This is particularly relevant when dealing with radioactive materials with high specific activity (>1.0 Ci/mmol). These compounds are shipped as solutions in ice and will not stay cold for more than 48 hours; they must be retrieved and put in cold storage immediately to prevent decomposition.

Foreign investigators should also be aware that compounds are shipped with a listed value for insurance purposes. Since this may cause problems with customs officials, investigators should determine in advance what steps should be taken to avoid these complications. Often an official statement that the compounds are for research only and have no commercial value is sufficient.

Helpful Notes:

Failure to comply with aforesaid guidelines may delay the processing of your request.

NOTE 1:  ETORPHINE AND DIPRENORPHINE - Request for either of these two compounds should be made on separate order forms when ordering additional compounds at the same time. Etorphine hydrochloride and diprenorphine (free base or hydrochloride) are Schedule II drugs, however etorphine free base is a Schedule I drug. Therefore, etorphine free base should be ordered using DEA Form-222 as is appropriate for all Schedule I drugs.

NOTE 2:  CARFENTANIL, ETORPHINE AND DIPRENORPHINE – The DEA registration of a research investigator requesting these compounds must show the proper registration for such compounds.

[marketresearchintent]

Catalyst Handling Services Market: Maximizing Catalyst Life Through Effective Handling Solutions

The Catalyst Handling Services Market is a niche but critical sector that supports the efficiency of chemical reactions, particularly in industries such as oil and gas, petrochemicals, and pharmaceuticals. Valued at USD 0.6 billion in 2023, this market is set to surpass USD 0.7 billion by 2030, growing at a CAGR of 4.1% during the forecast period from 2024 to 2030. This growth can be attributed to various factors, including rising industrial demands, technological advancements, and the increasing complexity of refining processes.

In this article, we will explore the key aspects driving the market, current trends, and what to expect in the near future.

What are Catalyst Handling Services?

Catalyst handling services encompass a range of specialized services that focus on the safe, efficient, and precise handling of catalysts in reactors and other industrial systems. These services include loading, unloading, screening, and reactivation of catalysts, which are critical in optimizing the performance of chemical processes.

Access Full Report @ https://intentmarketresearch.com/latest-reports/catalyst-handling-services-market-3144.html 

Key Drivers of the Catalyst Handling Services Market

Growing Demand in the Oil and Gas Sector

The oil and gas industry is one of the primary consumers of catalyst handling services. As global energy demands rise, refineries are under increasing pressure to enhance their output. Catalysts play a vital role in refining crude oil into usable products, and the efficient management of these catalysts is crucial to the success of refining operations.

Technological Advancements in Catalyst Handling

Technology is transforming the way catalyst handling services are delivered. Innovations such as automated catalyst loading systems, robotic inspections, and advanced monitoring tools are improving the safety, efficiency, and speed of these operations. Companies are increasingly adopting these advancements to minimize downtime and enhance the performance of their reactors.

Increasing Complexity in Petrochemical Processes

With the petrochemical industry evolving, processes are becoming more complex, and catalysts are being pushed to their limits. This has led to a rise in the demand for specialized catalyst handling services that ensure optimal performance, longevity, and safety in these high-stakes environments.

Challenges Facing the Catalyst Handling Services Market

Stringent Environmental Regulations

As global awareness of environmental issues grows, industries are facing stricter regulations on emissions and waste management. Catalyst handling services must adhere to these regulations, particularly in terms of catalyst disposal and regeneration. Non-compliance can result in heavy fines, which is pushing companies to invest in more sustainable practices.

High Cost of Catalyst Replacement

Catalysts are often expensive, and replacing them can be a significant financial burden for companies. This is why efficient catalyst handling services that extend the life of the catalysts through reactivation and regeneration are in high demand.

Skilled Labor Shortage

Catalyst handling is a highly specialized job that requires trained professionals. However, there is a shortage of skilled labor in this field, which is limiting the growth of the market. Companies are investing in training programs and automation to bridge this gap.

Market Segmentation

By Service Type

Catalyst Loading: Ensuring the proper and safe placement of catalysts within reactors.

Unloading: Safely removing spent catalysts for regeneration or disposal.

Screening: Analyzing the condition of used catalysts to determine their effectiveness.

Regeneration: Extending the life of catalysts by reactivating their properties.

By End-Use Industry

Oil & Gas

Petrochemical

Chemical Manufacturing

Pharmaceutical

Each sector has specific requirements, but the oil and gas industry remains the largest consumer of catalyst handling services.

Download Sample Report @ https://intentmarketresearch.com/request-sample/catalyst-handling-services-market-3144.html

Geographical Insights

North America

North America, particularly the U.S., holds a significant share in the catalyst handling services market, driven by its large oil and gas sector. Additionally, the presence of major refineries and chemical manufacturing plants further boosts the demand.

Asia-Pacific

The Asia-Pacific region is projected to experience the fastest growth due to the rising industrialization in countries like China and India. The growing petrochemical and refining industries in these nations are fueling the demand for catalyst handling services.

Europe

Europe is another key market, particularly in the pharmaceutical and chemical sectors. Stringent environmental regulations in the EU also drive the demand for efficient catalyst management and disposal services.

Key Players in the Catalyst Handling Services Market

Cat Tech International Ltd.

Known for its innovative catalyst handling solutions, Cat Tech provides services globally and is particularly strong in North America and Europe.

CR Asia Group

A leading name in the Asia-Pacific region, CR Asia specializes in a variety of industrial services, including catalyst handling, which is a core offering of the company.

Mourik International

Mourik International is a major player in Europe, known for its cutting-edge solutions in the chemical and petrochemical industries.

Emerging Trends in the Catalyst Handling Services Market

Automation and Robotics

Automation is revolutionizing catalyst handling services, reducing the need for human intervention and increasing safety in hazardous environments. Robotics, in particular, is becoming popular for tasks such as catalyst loading and reactor inspection.

Sustainability Initiatives

With sustainability becoming a major focus for industries, companies offering catalyst handling services are increasingly adopting eco-friendly practices. These include the reactivation and recycling of catalysts, reducing the environmental footprint of industrial processes.

Remote Monitoring and Diagnostics

Advanced monitoring systems now allow for the remote analysis of catalyst performance, enabling predictive maintenance and reducing unplanned downtimes. This trend is expected to grow as more companies prioritize operational efficiency.

Future Outlook for the Catalyst Handling Services Market

The catalyst handling services market is set to grow steadily over the next decade, driven by the increasing complexity of industrial processes and the demand for operational efficiency. While challenges such as skilled labor shortages and stringent regulations remain, technological advancements in automation and sustainability are expected to offset these hurdles.

Conclusion

The Catalyst Handling Services Market is poised for significant growth, driven by rising demand from the oil and gas, petrochemical, and pharmaceutical industries. As technology continues to evolve, companies offering these services are likely to adopt more automated, efficient, and environmentally friendly practices. With a projected market size of USD 0.7 billion by 2030, the sector presents lucrative opportunities for innovation and expansion.

FAQs

What are catalyst handling services? Catalyst handling services involve the safe and efficient management of catalysts in industrial processes, including loading, unloading, and regeneration.

What industries use catalyst handling services? Industries such as oil and gas, petrochemicals, pharmaceuticals, and chemicals are the primary consumers of catalyst handling services.

What are the key challenges in the catalyst handling services market? Some challenges include stringent environmental regulations, high costs of catalyst replacement, and a shortage of skilled labor.

How is technology impacting the catalyst handling services market? Technological advancements like automation, robotics, and remote monitoring are transforming catalyst handling services by improving safety, efficiency, and operational performance.

What is the future outlook for the catalyst handling services market? The market is expected to grow at a CAGR of 4.1%, reaching over USD 0.7 billion by 2030, driven by increasing industrial demands and technological innovations.

About Us

Intent Market Research (IMR) is dedicated to delivering distinctive market insights, focusing on the sustainable and inclusive growth of our clients. We provide in-depth market research reports and consulting services, empowering businesses to make informed, data-driven decisions.

Our market intelligence reports are grounded in factual and relevant insights across various industries, including chemicals & materials, healthcare, food & beverage, automotive & transportation, energy & power, packaging, industrial equipment, building & construction, aerospace & defense, and semiconductor & electronics, among others.

We adopt a highly collaborative approach, partnering closely with clients to drive transformative changes that benefit all stakeholders. With a strong commitment to innovation, we aim to help businesses expand, build sustainable advantages, and create meaningful, positive impacts.

Contact Us

sales@intentmarketresearch.com

US: +1 463-583-2713